Keros Therapeutics
H‑1B Sponsor Verified
Yes. Keros Therapeutics filed 7 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2022–2025, including 2 in 2025. The average H-1B salary is $207,571 and the most sponsored role is Executive Director, Pharmacovigilance.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: May 8, 2025.
LinkedIn ↗Latest Year Filings
2
In 2025
↗ Filter by year
Total H‑1B Filings
7
Since 2020
↗ View records
Avg Annual Salary
$207,571
All years combined
↗ View chart
Top Role
Executive Director, Pharmacovigila…
↗ Click to filter
Filing trend
H‑1B filings by year for Keros Therapeutics
| Year | LCA filings | Avg salary |
|---|---|---|
| 2025 | 2 | $191,500 |
| 2024 | 1 | $180,000 |
| 2023 | 2 | $155,000 |
| 2022 | 2 | $290,000 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary